4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-24-050147
Chief Financial Officer sold 1,695 shares at $6.38 ($10,814)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2024-04-29 | Sale | −1,695 | $6.38 | $10,814 | 339,803 | D |
| Open-market sales · 1,695 sh · avg $6.38 · $10,814 | |||||||
Loading xslF345X05/ownership.xml…